Cdc37 Antibodies

Santa Cruz Biotechnology delivers a wide array of Cdc37 monoclonal antibodies for research in cell cycle regulation and protein folding. Cdc37 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cdc37 is a co-chaperone that plays a critical role in the stabilization and activation of protein kinases, which are essential for cell signaling and regulation of the cell cycle. By facilitating proper folding and function of kinases, Cdc37 maintains cellular homeostasis and responds to stress signals. Dysregulation of Cdc37 has been implicated in various diseases, including cancer, making it an important target for therapeutic research. Understanding Cdc37's interaction with protein kinases can provide valuable insights into cellular signaling pathways and disease mechanisms. Research utilizing Cdc37 monoclonal antibodies has revealed significant findings about protein kinase regulation and cellular stress responses. Investigating Cdc37's role in disease progression continues to yield important discoveries about potential therapeutic approaches. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of Cdc37's functions in health and disease.